Abstract

BackgroundThe resistance of Neisseria gonorrhoeae to ceftriaxone is unusual in Switzerland. The underlying genotype responsible for resistance is suspected to be novel. Generally, resistance in Neisseria gonorrhoeae (Ng) involves a comprehensive set of genes with many different mutations leading to resistance to different β-lactams and fluoroquinolones.Case presentationA patient had a positive result from specific PCR for Ng. We routinely culture all clinical specimens with a positive NG-PCR. In this particular case, we isolated a strain with resistance to ceftriaxone in Switzerland. A total of seven different genes (penA, ponA, porinB, mtr, gyrA, parC, 23S rRNA gene) in this strain were partially sequenced for comparison with phenotypic susceptibility testing. Interestingly, two different mutations in the porinB gene were observed, and data on this gene are limited. Information on the identified allele type of the penA gene is very limited as well. Three different mutations of parC and gyrA that correlate with ciprofloxacin resistance were found. The combination of ceftriaxone and ciprofloxacin resistance makes an appropriate treatment difficult to obtain due to multidrug resistance.ConclusionThe combined results for all genes show the appearance of new mutations in central Europe either due to worldwide spread or the emergence of new genetic combinations of mutations.

Highlights

  • The resistance of Neisseria gonorrhoeae to ceftriaxone is unusual in Switzerland

  • Decreased susceptibility of Neisseria gonorrhoeae (Ng) to cefixime and ceftriaxone has been reported in Switzerland; very few clinical specimens have a MIC ≥ 0.25 mg/l [1], which is above the EUCAST (European Committee on Antimicrobial Susceptibility Testing) breakpoint of 0.125 mg/l [2]

  • We describe the molecular characterization of an Ng strain found in Switzerland with an unusual combination of mutations in relevant genes

Read more

Summary

Conclusion

The combined results for all genes show the appearance of new mutations in central Europe either due to worldwide spread or the emergence of new genetic combinations of mutations.

Background
Discussion and conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call